nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—Clonidine—CYP1A1—breast cancer	0.0532	0.343	CrCbGaD
Lofexidine—Clonidine—CYP2D6—breast cancer	0.0396	0.255	CrCbGaD
Lofexidine—Clonidine—CYP3A4—breast cancer	0.034	0.219	CrCbGaD
Lofexidine—Clonidine—ABCB1—breast cancer	0.0283	0.182	CrCbGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CD—breast cancer	0.000447	0.00053	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IL2—breast cancer	0.000445	0.000527	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BMP2—breast cancer	0.000443	0.000525	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTHLH—breast cancer	0.000443	0.000525	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP3A4—breast cancer	0.00044	0.00052	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRL—breast cancer	0.000439	0.000519	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR1—breast cancer	0.000439	0.000519	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADAM10—breast cancer	0.000432	0.000512	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STK11—breast cancer	0.000432	0.000512	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP1B1—breast cancer	0.000432	0.000512	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDNRB—breast cancer	0.000429	0.000508	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLG—breast cancer	0.000428	0.000506	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PGR—breast cancer	0.000425	0.000503	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HSP90AA1—breast cancer	0.000424	0.000502	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—THBS1—breast cancer	0.000423	0.000501	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT2—breast cancer	0.000423	0.000501	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF10—breast cancer	0.000421	0.000498	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOA1—breast cancer	0.000412	0.000488	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP19A1—breast cancer	0.000406	0.000481	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—STK11—breast cancer	0.000406	0.000481	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CD—breast cancer	0.000406	0.000481	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFA—breast cancer	0.000406	0.00048	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FLT1—breast cancer	0.000404	0.000478	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SQSTM1—breast cancer	0.000402	0.000476	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF3—breast cancer	0.000402	0.000476	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFBR2—breast cancer	0.0004	0.000474	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CG—breast cancer	0.0004	0.000473	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAG1—breast cancer	0.000397	0.00047	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH3—breast cancer	0.000395	0.000468	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PARP1—breast cancer	0.000395	0.000468	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITPR1—breast cancer	0.000394	0.000466	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB4—breast cancer	0.000391	0.000463	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP3—breast cancer	0.000391	0.000463	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT5A—breast cancer	0.000391	0.000463	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CALCA—breast cancer	0.00039	0.000462	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CB—breast cancer	0.00039	0.000462	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SRC—breast cancer	0.000389	0.00046	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RPS6—breast cancer	0.000386	0.000457	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF4—breast cancer	0.000383	0.000453	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCR4—breast cancer	0.000381	0.000451	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL12—breast cancer	0.000381	0.000451	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SMAD4—breast cancer	0.000379	0.000448	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—breast cancer	0.000379	0.000448	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—COMT—breast cancer	0.000378	0.000447	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1R—breast cancer	0.000376	0.000446	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTP1—breast cancer	0.000376	0.000445	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL8—breast cancer	0.000375	0.000444	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PAK1—breast cancer	0.000374	0.000443	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMOX1—breast cancer	0.000371	0.000439	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ITPR1—breast cancer	0.00037	0.000438	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HES1—breast cancer	0.00037	0.000438	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TCF7L2—breast cancer	0.000368	0.000435	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLA2G4A—breast cancer	0.000368	0.000435	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NCOR1—breast cancer	0.000368	0.000435	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT2—breast cancer	0.000366	0.000433	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CSF2—breast cancer	0.000364	0.00043	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF1—breast cancer	0.000364	0.00043	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CG—breast cancer	0.000363	0.00043	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—RAF1—breast cancer	0.000363	0.000429	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRG1—breast cancer	0.000361	0.000427	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—H2AFX—breast cancer	0.000358	0.000424	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IL2—breast cancer	0.000358	0.000424	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—MAPK3—breast cancer	0.000358	0.000424	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCB1—breast cancer	0.000356	0.000421	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—E2F1—breast cancer	0.000356	0.000421	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HSP90AA1—breast cancer	0.000355	0.00042	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH2—breast cancer	0.000355	0.00042	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	0.000354	0.000419	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CD—breast cancer	0.000352	0.000416	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TYMS—breast cancer	0.00035	0.000414	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—breast cancer	0.000347	0.000411	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOR1—breast cancer	0.000346	0.000409	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTM1—breast cancer	0.000346	0.000409	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLA2G4A—breast cancer	0.000346	0.000409	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR1—breast cancer	0.000345	0.000408	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRL—breast cancer	0.000345	0.000408	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SPP1—breast cancer	0.000342	0.000405	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL8—breast cancer	0.00034	0.000403	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STK11—breast cancer	0.00034	0.000402	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADAM10—breast cancer	0.00034	0.000402	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB3—breast cancer	0.000338	0.0004	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGFR2—breast cancer	0.000338	0.0004	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLG—breast cancer	0.000336	0.000398	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT2—breast cancer	0.000332	0.000393	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GPX1—breast cancer	0.000331	0.000392	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF10—breast cancer	0.000331	0.000391	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP1A1—breast cancer	0.000328	0.000388	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL2—breast cancer	0.000325	0.000385	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ERCC2—breast cancer	0.000325	0.000385	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TERT—breast cancer	0.000324	0.000384	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—KRAS—breast cancer	0.000322	0.000381	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CD—breast cancer	0.000319	0.000378	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFA—breast cancer	0.000319	0.000378	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGFR1—breast cancer	0.000315	0.000372	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFBR2—breast cancer	0.000314	0.000372	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HIF1A—breast cancer	0.00031	0.000367	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITPR1—breast cancer	0.000309	0.000366	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB4—breast cancer	0.000307	0.000364	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT5A—breast cancer	0.000307	0.000364	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP3—breast cancer	0.000307	0.000364	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CB—breast cancer	0.000307	0.000363	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—breast cancer	0.000305	0.000362	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—breast cancer	0.000303	0.000358	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CAV1—breast cancer	0.0003	0.000355	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SMAD4—breast cancer	0.000298	0.000352	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KDR—breast cancer	0.000296	0.000351	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1R—breast cancer	0.000296	0.00035	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CA—breast cancer	0.000296	0.00035	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL8—breast cancer	0.000295	0.000349	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HES1—breast cancer	0.000291	0.000344	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NCOR1—breast cancer	0.000289	0.000342	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLA2G4A—breast cancer	0.000289	0.000342	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—breast cancer	0.000289	0.000342	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TP53—breast cancer	0.000286	0.000339	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CSF2—breast cancer	0.000286	0.000338	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF1—breast cancer	0.000286	0.000338	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FN1—breast cancer	0.000285	0.000338	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—RAF1—breast cancer	0.000285	0.000337	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRG1—breast cancer	0.000284	0.000336	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NFKBIA—breast cancer	0.000282	0.000334	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAV1—breast cancer	0.000282	0.000333	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—H2AFX—breast cancer	0.000282	0.000333	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2—breast cancer	0.000281	0.000333	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—E2F1—breast cancer	0.00028	0.000331	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH1—breast cancer	0.000279	0.00033	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CB—breast cancer	0.000278	0.000329	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—HRAS—breast cancer	0.000274	0.000324	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KIT—breast cancer	0.000273	0.000323	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APC—breast cancer	0.000273	0.000323	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CG—breast cancer	0.000273	0.000323	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGF—breast cancer	0.00027	0.000319	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SPP1—breast cancer	0.000269	0.000318	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL8—breast cancer	0.000267	0.000317	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB3—breast cancer	0.000266	0.000315	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGFR2—breast cancer	0.000265	0.000314	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAPK3—breast cancer	0.000261	0.000309	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BRAF—breast cancer	0.000257	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CG—breast cancer	0.000257	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2—breast cancer	0.000256	0.000303	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TERT—breast cancer	0.000255	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—breast cancer	0.00025	0.000296	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT2—breast cancer	0.00025	0.000296	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EGFR—breast cancer	0.000249	0.000294	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGFR1—breast cancer	0.000247	0.000293	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIF1A—breast cancer	0.000244	0.000288	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—breast cancer	0.000242	0.000286	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CD—breast cancer	0.00024	0.000284	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—breast cancer	0.000238	0.000281	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	0.000238	0.000281	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SERPINE1—breast cancer	0.000237	0.000281	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CAV1—breast cancer	0.000236	0.000279	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—KRAS—breast cancer	0.000235	0.000278	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KDR—breast cancer	0.000233	0.000276	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—breast cancer	0.000227	0.000269	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—breast cancer	0.000227	0.000268	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CD—breast cancer	0.000226	0.000267	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FN1—breast cancer	0.000224	0.000265	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—breast cancer	0.000223	0.000264	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	0.000222	0.000262	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	0.000219	0.00026	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	0.000216	0.000256	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MDM2—breast cancer	0.000215	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	0.000215	0.000254	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APC—breast cancer	0.000215	0.000254	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KIT—breast cancer	0.000215	0.000254	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RAF1—breast cancer	0.000214	0.000254	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RELA—breast cancer	0.000213	0.000253	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—breast cancer	0.000213	0.000252	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGF—breast cancer	0.000212	0.000251	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB2—breast cancer	0.000212	0.000251	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CB—breast cancer	0.000209	0.000248	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MTOR—breast cancer	0.000209	0.000248	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	0.000206	0.000243	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BRAF—breast cancer	0.000202	0.000239	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL8—breast cancer	0.000201	0.000238	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HRAS—breast cancer	0.0002	0.000236	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CB—breast cancer	0.000197	0.000233	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—breast cancer	0.000196	0.000233	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT2—breast cancer	0.000196	0.000232	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1B—breast cancer	0.000196	0.000232	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	0.000196	0.000231	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—breast cancer	0.000195	0.000231	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—breast cancer	0.000194	0.00023	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—breast cancer	0.000192	0.000228	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2—breast cancer	0.000192	0.000227	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—breast cancer	0.000191	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	0.000189	0.000223	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCND1—breast cancer	0.000187	0.000222	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JUN—breast cancer	0.000187	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	0.000187	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	0.000187	0.000221	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CTNNB1—breast cancer	0.000185	0.00022	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	0.000185	0.000219	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—breast cancer	0.000182	0.000215	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1A—breast cancer	0.000181	0.000214	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTEN—breast cancer	0.000181	0.000214	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—breast cancer	0.000178	0.000211	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK8—breast cancer	0.000177	0.000209	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—breast cancer	0.000176	0.000209	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTEN—breast cancer	0.00017	0.000201	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	0.00017	0.000201	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MDM2—breast cancer	0.000169	0.0002	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RAF1—breast cancer	0.000168	0.000199	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RELA—breast cancer	0.000168	0.000198	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SRC—breast cancer	0.000168	0.000198	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	0.000167	0.000197	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MTOR—breast cancer	0.000164	0.000195	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	0.000164	0.000195	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—breast cancer	0.000163	0.000193	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—breast cancer	0.000162	0.000191	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	0.000158	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	0.000157	0.000186	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK3—breast cancer	0.000154	0.000183	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	0.000154	0.000183	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	0.000153	0.000181	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—breast cancer	0.000151	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2—breast cancer	0.000151	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—breast cancer	0.00015	0.000178	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MYC—breast cancer	0.00015	0.000178	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—breast cancer	0.00015	0.000177	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCND1—breast cancer	0.000147	0.000174	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGFR—breast cancer	0.000147	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JUN—breast cancer	0.000147	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	0.000146	0.000173	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—breast cancer	0.000143	0.000169	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	0.000142	0.000169	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTEN—breast cancer	0.000142	0.000168	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	0.000139	0.000165	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KRAS—breast cancer	0.000139	0.000164	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	0.000139	0.000164	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SRC—breast cancer	0.000132	0.000156	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	0.000128	0.000152	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	0.000128	0.000151	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—breast cancer	0.000127	0.00015	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TP53—breast cancer	0.000123	0.000146	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	0.000121	0.000144	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CA—breast cancer	0.00012	0.000142	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MYC—breast cancer	0.000118	0.00014	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HRAS—breast cancer	0.000118	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	0.000118	0.000139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGFR—breast cancer	0.000115	0.000137	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—breast cancer	0.000113	0.000134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KRAS—breast cancer	0.000109	0.000129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—breast cancer	0.000104	0.000123	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	0.0001	0.000119	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—breast cancer	9.79e-05	0.000116	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TP53—breast cancer	9.7e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HRAS—breast cancer	9.27e-05	0.00011	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—breast cancer	8.88e-05	0.000105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—breast cancer	8.19e-05	9.69e-05	CbGpPWpGaD
